These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11193809)

  • 1. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease.
    Green PS; Simpkins JW
    Ann N Y Acad Sci; 2000; 924():93-8. PubMed ID: 11193809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-feminizing estrogens: a novel neuroprotective therapy.
    Petrone AB; Gatson JW; Simpkins JW; Reed MN
    Mol Cell Endocrinol; 2014 May; 389(1-2):40-7. PubMed ID: 24424441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and non-feminizing estrogen for Alzheimer's disease.
    Honjo H; Iwasa K; Fushiki S; Hosoda T; Tatsumi H; Mihara M; Hirasugi Y; Oida M; Kariya K; Kikuchi N; Kawata M
    Endocr J; 2003 Aug; 50(4):361-7. PubMed ID: 14599108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
    Birge SJ
    J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of non-feminizing estrogens in neuroprotection.
    Engler-Chiurazzi EB; Covey DF; Simpkins JW
    Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology.
    Simpkins JW; Wen Y; Perez E; Yang S; Wang X
    Ann N Y Acad Sci; 2005 Jun; 1052():233-42. PubMed ID: 16024766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
    Mills ZB; Faull RLM; Kwakowsky A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective actions of sex steroid hormones in Alzheimer's disease.
    Pike CJ; Carroll JC; Rosario ER; Barron AM
    Front Neuroendocrinol; 2009 Jul; 30(2):239-58. PubMed ID: 19427328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and Alzheimer's disease.
    van Duijn CM
    Maturitas; 1999 Mar; 31(3):201-5. PubMed ID: 10340279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.
    Mulnard RA; Corrada MM; Kawas CH
    Curr Neurol Neurosci Rep; 2004 Sep; 4(5):368-73. PubMed ID: 15324602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: an estrogen link?
    Beckmann CR
    Curr Opin Obstet Gynecol; 1997 Oct; 9(5):295-9. PubMed ID: 9360809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogens against Alzheimer disease? The female sexual hormone as a protective neurohormone].
    Behl C
    MMW Fortschr Med; 2001 May; 143 Suppl 2():33-5. PubMed ID: 11434254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens: mechanisms of neuroprotective effects.
    Petrovska S; Dejanova B; Jurisic V
    J Physiol Biochem; 2012 Sep; 68(3):455-60. PubMed ID: 22371015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.
    Herrera JL; Fernandez C; Diaz M; Cury D; Marin R
    Steroids; 2011 Aug; 76(9):840-4. PubMed ID: 21354436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestins and estrogens and Alzheimer's disease.
    Honjo H; Iwasa K; Kawata M; Fushiki S; Hosoda T; Tatsumi H; Oida N; Mihara M; Hirasugi Y; Yamamoto H; Kikuchi N; Kitawaki J
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):305-8. PubMed ID: 15860274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis.
    Solerte SB; Fioravanti M; Racchi M; Trabucchi M; Zanetti O; Govoni S
    Maturitas; 1999 Jan; 31(2):95-101. PubMed ID: 10227001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.